Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.548 | 1.157 | 1.00000 | 1.00000 | |
RegionR2 | -0.024 | 1.157 | 0.81690 | 1.00000 | |
RegionR3 | -1.276 | 1.157 | 0.89700 | 1.00000 | |
RegionR4 | 2.62 | 1.157 | 1.00000 | 1.00000 | |
RegionR5 | 0.184 | 1.157 | 0.52840 | 0.89079 | |
RegionR6 | -1.103 | 1.157 | 0.85518 | 1.00000 | |
RegionR7 | -3.309 | 1.157 | 1.00000 | 1.00000 | |
RegionR8 | 3.456 | 1.157 | 0.06479 | 0.49312 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.8 | 1.157 | 1.00000 | 1.00000 | |
RegenerationR2 | -1.339 | 1.157 | 0.11894 | 0.53678 | |
RegenerationR3 | -3.333 | 1.157 | 0.08078 | 0.46765 | |
RegenerationR4 | -1.851 | 1.157 | 0.72475 | 0.96314 | |
RegenerationR5 | -3.627 | 1.157 | 0.04168 | 0.33513 | |
RegenerationR6 | -4.2 | 1.157 | 0.04130 | 0.25424 | |
RegenerationBL | 0.786 | 1.157 | 0.58638 | 0.93708 | |
RegenerationTP | -0.379 | 1.157 | 0.90391 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
2. | MligTC455_53707 | 903 | 18.82 | Mlig455_001231 | Neo: - Age: Down-Up-Up Region-specific R2: 3.242 Region-enriched R2: 1.917/0.00133 Regeneration-downregulated BL: -2.295 Regeneration-depleted BL: -2.295 |
3.602 | 0.958 | - | 0.878 | - | 0.851 | 0.915 | Mlig455_001231 {REF} {Length: 737} {RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1310_60643.1, RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1509_13584, RNA1509_53181, RNA1509_55651, RNA815_32307.1} | |
3. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
3.556 | 0.912 | - | 0.876 | - | 0.978 | 0.790 | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
4. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 3.483 | 0.826 | - | 0.952 | - | 0.913 | 0.792 | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
5. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
3.423 | 0.852 | - | 0.954 | 0.740 | 0.877 | - | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
6. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
3.422 | 0.854 | - | 0.954 | 0.737 | 0.877 | - | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
7. | MligTC455_46725 | 1277 | 26.6 | Mlig455_002797, Mlig455_002811 | Neo: - Age: - Region-enriched R7: 2.089/0.02985 |
TMPRSS4 | 3.309 | 0.732 | - | 0.761 | - | 0.956 | 0.860 | Mlig455_002797 {REF} {Length: 1278} {Pfam: Trypsin [PF00089.28, score=217.0]; Trypsin-like peptidase domain [PF13365.8, score=29.1]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=177, Expect=8e-53]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=5e-49]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=283, Expect=4e-94]} {RNA1509_14801} {RNA1310_24334.1} {RNA815_10378} Mlig455_002811 {REF} {Length: 1406} {Pfam: Trypsin [PF00089.28, score=216.7]; Trypsin-like peptidase domain [PF13365.8, score=29.0]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=176, Expect=1e-52]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=3e-49]; ENSMUSG00000033825, Tpsb2, tryptase beta 2, [RH, Score=163, Expect=9e-48]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=285, Expect=7e-95]} {RNA1509_14801} {RNA1310_24334.1, RNA1509_14801} {RNA1509_14801, RNA815_10378} |
8. | MligTC455_32521 | 203 | 4.23 | Mlig455_040932 | Neo: - Age: Down-Down-Up Region-enriched R8: 3.877/0.00012 |
3.298 | - | - | 0.777 | 0.777 | 0.981 | 0.763 | Mlig455_040932 {REF} {Length: 1862} {RNA1310_21335.1} {RNA815_57481} | |
9. | MligTC455_36679 | 4666 | 97.21 | Mlig455_049598 | Neo: - Age: logFC(26M/2M)=-0.429 Region-enriched R8: 3.151/0.00004 |
3.177 | 0.723 | - | 0.793 | - | 0.711 | 0.950 | Mlig455_049598 {REF} {Length: 1229} {RNA1509_20268, RNA1509_24976} {RNA1310_46724, RNA1509_24976} {RNA1509_24976, RNA815_46768} | |
10. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 2.741 | - | - | 0.930 | - | 0.963 | 0.848 | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
11. | MligTC455_34949 | 30 | 0.63 | Mlig455_055437 | Neo: - Age: - |
RIMS1 | 2.737 | - | - | 0.932 | - | 0.982 | 0.823 | Mlig455_055437 {REF} {Length: 5246} {Pfam: C2 domain [PF00168.32, score=104.4]; PDZ domain [PF17820.3, score=39.9]; PDZ domain [PF00595.26, score=32.1]; Piccolo Zn-finger [PF05715.15, score=24.7]; PDZ domain [PF13180.8, score=24.0]; FYVE-type zinc finger [PF02318.18, score=19.4]} {Human: ENSG00000079841, RIMS1, regulating synaptic membrane exocytosis 1, [RH, Score=239, Expect=2e-63]; ENSG00000176406, RIMS2, regulating synaptic membrane exocytosis 2, [RH, Score=238, Expect=2e-63]} {Mouse: ENSMUSG00000037386, Rims2, regulating synaptic membrane exocytosis 2, [RH, Score=241, Expect=3e-64]; ENSMUSG00000111628, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]; ENSMUSG00000041670, Rims1, regulating synaptic membrane exocytosis 1, [RH, Score=240, Expect=1e-66]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [RH, Score=243, Expect=6e-65]} {Celegans: WBGene00006750, unc-10, Rab-3-interacting molecule unc-10, [RH, Score=187, Expect=1e-47]} {Smed: dd_Smed_v6_10734_0_1, dd_Smed_v6_10734_0_1, [RH, Score=281, Expect=6e-80]} {RNA1509_26372} {RNA1310_18417, RNA1509_26372} {RNA1509_26372, RNA815_9566} |
12. | MligTC455_44395 | 179 | 3.73 | Mlig455_054597, Mlig455_067604 | Neo: - Age: Up-Down-Down |
SLC8A1 | 2.735 | 0.951 | - | 0.851 | - | 0.933 | - | Mlig455_054597 {REF} {Length: 3516} {TRANSSPLICED} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=162.7]; Calx-beta domain [PF03160.16, score=142.8]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=23.2]; Domain of unknown function (DUF4843) [PF16132.7, score=18.7]} {Human: ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=518, Expect=1e-170]; ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=497, Expect=9e-163]} {Mouse: ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=513, Expect=1e-168]; ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=501, Expect=1e-164]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=510, Expect=7e-168]} {Celegans: WBGene00003568, ncx-3, Na/Ca eXchangers, [Score=532, Expect=7e-178]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [Score=492, Expect=2e-161]} {RNA1509_42629} {RNA1310_4660} {RNA815_14049} Mlig455_067604 {REF} {Length: 2698} {Pfam: Calx-beta domain [PF03160.16, score=145.3]; Sodium/calcium exchanger protein [PF01699.26, score=82.2]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=22.7]; Domain of unknown function (DUF4843) [PF16132.7, score=19.8]} {Human: ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=337, Expect=5e-104]; ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=327, Expect=2e-100]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=330, Expect=7e-102]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=328, Expect=8e-101]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=338, Expect=1e-104]} {Celegans: WBGene00003568, ncx-3, Na/Ca eXchangers, [Score=346, Expect=6e-109]} {Smed: dd_Smed_v6_7229_0_1, dd_Smed_v6_7229_0_1, [Score=321, Expect=2e-99]} {RNA1509_42629} {RNA1310_4546.1} {RNA815_14049} |
13. | MligTC455_36963 | 39 | 0.81 | Mlig455_050201 | Neo: - Age: Up-Down-Down |
AVPR1B | 2.732 | 0.942 | - | 0.811 | - | - | 0.979 | Mlig455_050201 {REF} {Length: 2792} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=152.5]; Olfactory receptor [PF13853.8, score=29.2]} {Human: ENSG00000198049, AVPR1B, arginine vasopressin receptor 1B, [Score=92.8, Expect=1e-19]} {Mouse: ENSMUSG00000049112, Oxtr, oxytocin receptor, [Score=94.0, Expect=3e-20]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=80.5, Expect=7e-16]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=79.0, Expect=3e-15]} {Smed: dd_Smed_v6_45004_0_1, dd_Smed_v6_45004_0_1, [Score=69.7, Expect=8e-13]} {RNA1310_72444} {RNA815_35126} |
14. | MligTC455_19694 | 101 | 2.1 | Mlig455_019126 | Neo: - Age: - |
HMCN1 | 2.726 | 0.955 | - | - | 0.784 | 0.987 | - | Mlig455_019126 {REF} {Length: 1904} {Pfam: Immunoglobulin domain [PF13927.8, score=96.3]; Immunoglobulin I-set domain [PF07679.18, score=82.1]; Immunoglobulin V-set domain [PF07686.19, score=63.8]; Immunoglobulin domain [PF00047.27, score=57.8]; Immunoglobulin domain [PF13895.8, score=55.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=88.6, Expect=8e-18]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=92.0, Expect=5e-19]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=88.6, Expect=6e-18]} {Dmel: FBgn0000071, Ama, Amalgam, [RH, Score=111, Expect=7e-27]} {Celegans: WBGene00004372, rig-5, NeuRonal IGCAM, [RH, Score=98.2, Expect=6e-22]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=64.3, Expect=1e-10]} {RNA1310_49122} {RNA815_40619} |
15. | MligTC455_17579 | 76 | 1.58 | Mlig455_042836, Mlig455_045854, Mlig455_045870 | Neo: - Age: - |
RNF217 | 2.716 | - | - | 0.865 | - | 0.979 | 0.872 | Mlig455_042836 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=75.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.6, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.0, Expect=4e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045854 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.7]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.8, Expect=2e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045870 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.9]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} |
16. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
2.715 | 0.788 | - | 0.980 | - | 0.947 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
17. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.684 | 0.806 | - | 0.968 | - | 0.910 | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
18. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 2.645 | 0.775 | - | 0.895 | - | 0.975 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
19. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.637 | 0.781 | - | 0.900 | - | 0.956 | - | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
20. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.594 | 0.725 | - | 0.907 | - | 0.962 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
21. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
2.588 | 0.717 | - | 0.912 | - | 0.959 | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
22. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 2.586 | 0.799 | - | 0.832 | - | 0.955 | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
23. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
2.58 | 0.732 | - | 0.962 | - | 0.886 | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
24. | MligTC455_12992 | 102 | 2.12 | Mlig455_034920 | Neo: - Age: - Region-enriched R2: 3.155/0.02568 |
RAC2 | 2.573 | - | - | 0.955 | 0.720 | 0.898 | - | Mlig455_034920 {REF} {Length: 3245} {Pfam: Ras family [PF00071.24, score=175.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=80.0]; ADP-ribosylation factor family [PF00025.23, score=32.7]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=277, Expect=1e-95]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=273, Expect=6e-94]} {Mouse: ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=275, Expect=3e-95]; ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=273, Expect=4e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=263, Expect=3e-90]} {Dmel: FBgn0010333, Rac1, [Score=270, Expect=2e-93]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=268, Expect=2e-92]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_31644} {RNA815_16762} |
25. | MligTC455_42785 | 79 | 1.65 | Mlig455_004724 | Neo: - Age: Down-Up-Down |
2.566 | - | - | 0.862 | - | 0.956 | 0.748 | Mlig455_004724 {REF} {Length: 1460} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1, RNA1509_29447} {RNA1509_29447, RNA815_16689.1} | |
26. | MligTC455_27313 | 61 | 1.27 | Mlig455_031814, Mlig455_047613 | Neo: - Age: - |
WSCD2 | 2.558 | 0.808 | - | 0.768 | - | 0.982 | - | Mlig455_031814 {REF} {Length: 844} {Pfam: WSC domain [PF01822.21, score=66.1]; PAN domain [PF00024.28, score=19.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=62.0, Expect=7e-11]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=60.5, Expect=1e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=56.6, Expect=3e-09]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=48.5, Expect=1e-06]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} Mlig455_047613 {REF} {Length: 843} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=5e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.9, Expect=4e-07]} {RNA1509_43359} {RNA1310_33892} {RNA815_23776.1} |
27. | MligTC455_38187 | 373 | 7.76 | Mlig455_014893, Mlig455_014894, Mlig455_015018, Mlig455_038636 | Neo: - Age: - |
KCNQ4, KCNQ5 | 2.542 | - | - | 0.745 | - | 0.961 | 0.836 | Mlig455_014893 {REF} {Length: 2201} {RNA1509_14697} {RNA1310_35101} {RNA815_16213} Mlig455_014894 {REF} {Length: 2033} {Pfam: Ion transport protein [PF00520.33, score=97.0]; Ion channel [PF07885.18, score=51.5]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [Score=360, Expect=7e-112]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [Score=359, Expect=1e-111]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [Score=419, Expect=1e-137]} {Celegans: WBGene00002233, kqt-1, KQT-1 potassium channel; Potassium channel, KvQLT family, [Score=408, Expect=3e-133]} {Smed: dd_Smed_v6_12681_0_1, dd_Smed_v6_12681_0_1, [Score=494, Expect=3e-165]} {RNA1509_14697} {RNA1310_2072.1} {RNA815_522} Mlig455_015018 {REF} {Length: 3026} {Pfam: Ion transport protein [PF00520.33, score=102.9]; KCNQ voltage-gated potassium channel [PF03520.16, score=97.5]; Ion channel [PF07885.18, score=50.7]} {Human: ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [RH, Score=438, Expect=6e-140]} {Mouse: ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [RH, Score=431, Expect=1e-137]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [RH, Score=452, Expect=5e-142]} {Celegans: WBGene00002233, kqt-1, KQT-1 potassium channel; Potassium channel, KvQLT family, [Score=439, Expect=1e-140]} {Smed: dd_Smed_v6_12681_0_1, dd_Smed_v6_12681_0_1, [RH, Score=529, Expect=7e-174]} {RNA1509_53461} {RNA1310_5448} {RNA815_4132} Mlig455_038636 {REF} {Length: 5388} {TRANSSPLICED} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=122.0]; Ion transport protein [PF00520.33, score=102.5]; Ion channel [PF07885.18, score=50.3]} {Human: ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [RH, Score=456, Expect=9e-145]} {Mouse: ENSMUSG00000028631, Kcnq4, potassium voltage-gated channel, subfamily Q, member 4, [RH, Score=449, Expect=4e-142]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [RH, Score=462, Expect=1e-143]} {Celegans: WBGene00002233, kqt-1, KQT-1 potassium channel; Potassium channel, KvQLT family, [Score=442, Expect=5e-140]} {Smed: dd_Smed_v6_12681_0_1, dd_Smed_v6_12681_0_1, [Score=537, Expect=2e-174]} {RNA1509_53461} {RNA1310_2072.1} {RNA815_4132} |
28. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.532 | 0.781 | - | 0.793 | - | 0.958 | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
29. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 2.527 | 0.804 | - | 0.957 | - | 0.766 | - | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
30. | MligTC455_45898 | 87 | 1.82 | Mlig455_058293 | Neo: - Age: - |
CUX2 | 2.526 | 0.770 | - | 0.806 | - | 0.950 | - | Mlig455_058293 {REF} {Length: 4328} {Pfam: CUT domain [PF02376.17, score=197.2]; Homeodomain [PF00046.31, score=53.8]; Homeobox KN domain [PF05920.13, score=29.1]} {Human: ENSG00000111249, CUX2, cut like homeobox 2, [Score=144, Expect=3e-34]} {Mouse: ENSMUSG00000042589, Cux2, cut-like homeobox 2, [Score=148, Expect=1e-35]} {Dmel: FBgn0004198, ct, cut, [Score=123, Expect=4e-28]} {Celegans: WBGene00000464, ceh-44, Homeobox protein cut-like ceh-44, [RH, Score=142, Expect=4e-34]} {Smed: dd_Smed_v6_13843_0_1, dd_Smed_v6_13843_0_1, [Score=125, Expect=6e-29]} {RNA1310_11859} {RNA815_40841} |
31. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 2.507 | - | - | 0.801 | - | 0.979 | 0.727 | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
32. | MligTC455_51314 | 525 | 10.93 | Mlig455_017296, Mlig455_045285 | Neo: - Age: - Region-enriched R2: 2.314/0.04004 |
2.495 | - | - | 0.716 | - | 0.824 | 0.955 | Mlig455_017296 {REF} {Length: 2087} {RNA1310_34789} {RNA815_64894} Mlig455_045285 {REF} {Length: 1644} {RNA1310_34789} {RNA815_64894} |
|
33. | MligTC455_41402 | 82 | 1.72 | Mlig455_035255 | Neo: - Age: Down-Up-Down |
BSG | 2.487 | - | - | 0.799 | - | 0.970 | 0.718 | Mlig455_035255 {REF} {Length: 1671} {Pfam: Immunoglobulin domain [PF13927.8, score=36.8]; Immunoglobulin domain [PF00047.27, score=33.5]; Immunoglobulin I-set domain [PF07679.18, score=27.5]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=21.9]} {Human: ENSG00000172270, BSG, basigin (Ok blood group), [Score=53.5, Expect=6e-08]} {RNA1509_26299} {RNA1310_20860, RNA1509_26299} {RNA1509_26299, RNA815_11415} |
34. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
2.474 | 0.789 | - | 0.731 | - | 0.954 | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
35. | MligTC455_46250 | 250 | 5.22 | Mlig455_061252, Mlig455_062640 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.242/0.04858 |
ANK3 | 2.434 | 0.969 | - | 0.713 | - | 0.752 | - | Mlig455_061252 {REF} {Length: 6298} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=515.9]; Ankyrin repeat [PF00023.32, score=428.9]; Ankyrin repeats (many copies) [PF13637.8, score=422.7]; Ankyrin repeat [PF13606.8, score=373.9]; Ankyrin repeats (many copies) [PF13857.8, score=357.7]; Ion transport protein [PF00520.33, score=32.5]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=331, Expect=3e-91]; ENSG00000029534, ANK1, ankyrin 1, [Score=323, Expect=9e-89]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=340, Expect=4e-94]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [RH, Score=1282, Expect=0.0]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=1209, Expect=0.0]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [Score=1539, Expect=0.0]} {RNA1509_19181} {RNA1310_8680} {RNA815_14387} Mlig455_062640 {REF} {Length: 5955} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=524.6]; Ankyrin repeat [PF00023.32, score=431.5]; Ankyrin repeats (many copies) [PF13637.8, score=428.3]; Ankyrin repeat [PF13606.8, score=380.8]; Ankyrin repeats (many copies) [PF13857.8, score=357.0]; Ion transport protein [PF00520.33, score=32.4]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=338, Expect=2e-93]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=345, Expect=9e-96]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [RH, Score=1318, Expect=0.0]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [RH, Score=1261, Expect=0.0]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [RH, Score=1582, Expect=0.0]} {RNA1509_19181} {RNA1310_6198, RNA1509_19181} {RNA1509_19181, RNA815_14387} |
36. | MligTC455_16101 | 431 | 8.98 | Mlig455_041713, Mlig455_042060, Mlig455_042270 | Neo: - Age: - Region-enriched R2: 1.718/0.04648 |
FARP2 | 2.393 | 0.713 | - | 0.962 | 0.718 | - | - | Mlig455_041713 {REF} {Length: 5134} {TRANSSPLICED} {Pfam: FERM C-terminal PH-like domain [PF09380.12, score=85.6]; PH domain [PF00169.31, score=67.5]; FERM N-terminal domain [PF09379.12, score=57.5]; FERM central domain [PF00373.20, score=50.0]; RhoGEF domain [PF00621.22, score=43.8]; FERM adjacent (FA) [PF08736.13, score=43.8]} {Human: ENSG00000006607, FARP2, FERM, ARH/RhoGEF and pleckstrin domain protein 2, [RH, Score=337, Expect=2e-101]; ENSG00000152767, FARP1, FERM, ARH/RhoGEF and pleckstrin domain protein 1, [RH, Score=327, Expect=9e-96]} {Mouse: ENSMUSG00000034066, Farp2, FERM, RhoGEF and pleckstrin domain protein 2, [RH, Score=344, Expect=2e-102]} {Dmel: FBgn0265082, Cdep, Chondrocyte-derived ezrin-like domain containing protein, [RH, Score=432, Expect=3e-126]} {Celegans: WBGene00001490, frm-3, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [RH, Score=362, Expect=3e-106]} {Smed: dd_Smed_v6_5600_0_1, dd_Smed_v6_5600_0_1, [RH, Score=464, Expect=1e-139]} {RNA1509_15749} {RNA1310_5327.1, RNA1509_15749} {RNA1509_15749, RNA815_12523} Mlig455_042060 {REF} {Length: 1546} {TRANSSPLICED} {Pfam: FERM N-terminal domain [PF09379.12, score=60.4]; FERM central domain [PF00373.20, score=52.8]; FERM C-terminal PH-like domain [PF09380.12, score=46.4]} {Human: ENSG00000006607, FARP2, FERM, ARH/RhoGEF and pleckstrin domain protein 2, [Score=245, Expect=5e-76]; ENSG00000152767, FARP1, FERM, ARH/RhoGEF and pleckstrin domain protein 1, [Score=239, Expect=1e-72]; ENSG00000165694, FRMD7, FERM domain containing 7, [Score=238, Expect=6e-73]} {Mouse: ENSMUSG00000034066, Farp2, FERM, RhoGEF and pleckstrin domain protein 2, [Score=247, Expect=2e-74]; ENSMUSG00000025555, Farp1, FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), [Score=243, Expect=5e-73]} {Dmel: FBgn0265082, Cdep, Chondrocyte-derived ezrin-like domain containing protein, [Score=293, Expect=9e-98]} {Celegans: WBGene00001490, frm-3, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [Score=256, Expect=3e-78]} {Smed: dd_Smed_v6_5600_0_1, dd_Smed_v6_5600_0_1, [Score=329, Expect=4e-103]} {RNA1509_15749} {RNA1310_24159} {RNA815_12523} Mlig455_042270 {REF} {Length: 5136} {TRANSSPLICED} {Pfam: FERM C-terminal PH-like domain [PF09380.12, score=85.6]; PH domain [PF00169.31, score=67.2]; FERM N-terminal domain [PF09379.12, score=57.5]; FERM central domain [PF00373.20, score=49.9]; RhoGEF domain [PF00621.22, score=43.8]; FERM adjacent (FA) [PF08736.13, score=43.7]} {Human: ENSG00000006607, FARP2, FERM, ARH/RhoGEF and pleckstrin domain protein 2, [RH, Score=337, Expect=2e-101]; ENSG00000152767, FARP1, FERM, ARH/RhoGEF and pleckstrin domain protein 1, [RH, Score=326, Expect=1e-95]} {Mouse: ENSMUSG00000034066, Farp2, FERM, RhoGEF and pleckstrin domain protein 2, [RH, Score=345, Expect=2e-102]} {Dmel: FBgn0265082, Cdep, Chondrocyte-derived ezrin-like domain containing protein, [RH, Score=433, Expect=2e-126]} {Celegans: WBGene00001490, frm-3, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [RH, Score=362, Expect=2e-106]} {Smed: dd_Smed_v6_5600_0_1, dd_Smed_v6_5600_0_1, [RH, Score=464, Expect=1e-139]} {RNA1509_15749, RNA1509_55939} {RNA1310_5327.1, RNA1509_55939} {RNA1509_55939, RNA815_12523} |
37. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 1.909 | - | - | 0.966 | - | 0.943 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
38. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 1.907 | - | - | 0.937 | - | 0.970 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
39. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 1.907 | - | - | 0.949 | - | 0.958 | - | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
40. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 1.907 | - | - | 0.978 | - | 0.929 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
41. | MligTC455_40227 | 12 | 0.26 | Mlig455_010749 | Neo: - Age: - |
GRIK2 | 1.89 | - | - | 0.930 | - | 0.960 | - | Mlig455_010749 {REF} {Length: 2895} {Pfam: Ligand-gated ion channel [PF00060.28, score=133.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=306, Expect=6e-90]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=305, Expect=4e-89]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=303, Expect=1e-88]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=306, Expect=3e-90]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=303, Expect=2e-89]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=302, Expect=3e-88]} {Dmel: FBgn0039927, CG11155, [Score=291, Expect=2e-84]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=262, Expect=8e-75]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=336, Expect=1e-100]} {RNA1310_47182} {RNA815_48326} |
42. | MligTC455_53435 | 190 | 3.96 | Mlig455_045425, Mlig455_065748 | Neo: - Age: - Region-enriched R2: 4.111/0.00023 |
SYT9 | 1.884 | - | - | 0.970 | - | 0.914 | - | Mlig455_045425 {REF} {Length: 2615} {RNA1509_46689} {RNA1310_15031, RNA1509_46689} {RNA1509_46689, RNA815_18779.1} Mlig455_065748 {REF} {Length: 3143} {Pfam: C2 domain [PF00168.32, score=116.1]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=162, Expect=4e-42]; ENSG00000213023, SYT3, synaptotagmin 3, [Score=157, Expect=5e-40]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=162, Expect=3e-42]; ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=156, Expect=1e-39]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [RH, Score=197, Expect=1e-54]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=144, Expect=8e-37]} {Smed: dd_Smed_v6_6730_0_1, dd_Smed_v6_6730_0_1, [Score=155, Expect=5e-41]} {RNA1509_46689} {RNA1310_15031} {RNA815_18779.1} |
43. | MligTC455_19438 | 27 | 0.56 | Mlig455_016816 | Neo: - Age: - |
RXRA | 1.88 | - | - | 0.929 | - | - | 0.951 | Mlig455_016816 {REF} {Length: 1783} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=72.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=23.6]} {Human: ENSG00000186350, RXRA, retinoid X receptor alpha, [Score=82.0, Expect=2e-16]} {Mouse: ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=80.9, Expect=3e-16]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=79.3, Expect=1e-15]; ENSMUSG00000015843, Rxrg, retinoid X receptor gamma, [Score=77.4, Expect=5e-15]} {Dmel: FBgn0003964, usp, ultraspiracle, [Score=75.5, Expect=2e-14]} {Celegans: WBGene00003651, nhr-61, Nuclear hormone receptor family member nhr-61, [Score=86.7, Expect=2e-18]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=79.0, Expect=1e-15]} {RNA1310_147040} |
44. | MligTC455_14308 | 56 | 1.17 | Mlig455_058785 | Neo: - Age: - |
CNBD2 | 1.878 | - | - | 0.903 | - | 0.975 | - | Mlig455_058785 {REF} {Length: 2153} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=56.0]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=69.7, Expect=7e-12]} {Mouse: ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=71.2, Expect=9e-13]} {Dmel: FBgn0085421, Epac, Exchange protein directly activated by cAMP, [Score=54.7, Expect=2e-07]} {RNA1310_32252} {RNA815_58357} |
45. | MligTC455_00282 | 64 | 1.34 | Mlig455_011958 | Neo: - Age: - |
1.877 | - | - | 0.921 | - | - | 0.956 | Mlig455_011958 {REF} {Length: 258} {NoTransDecoderORF} | |
46. | MligTC455_13072 | 18 | 0.37 | Mlig455_066620 | Neo: - Age: - |
HDC | 1.876 | - | - | 0.902 | - | 0.974 | - | Mlig455_066620 {REF} {Length: 3571} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=359.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=26.2]} {Human: ENSG00000140287, HDC, histidine decarboxylase, [RH, Score=493, Expect=1e-167]} {Mouse: ENSMUSG00000027360, Hdc, histidine decarboxylase, [Score=466, Expect=9e-157]} {Dmel: FBgn0005619, Hdc, Histidine decarboxylase, [Score=516, Expect=5e-177]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=404, Expect=8e-133]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=409, Expect=9e-137]} {RNA1310_91546} |
47. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 1.875 | - | - | 0.917 | - | 0.958 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
48. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 1.872 | - | - | 0.901 | - | 0.971 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
49. | MligTC455_00245 | 15 | 0.32 | Mlig455_040042 | Neo: - Age: - |
GPR17 | 1.869 | - | - | 0.877 | - | 0.992 | - | Mlig455_040042 {REF} {Length: 1332} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Human: ENSG00000144230, GPR17, G protein-coupled receptor 17, [Score=48.9, Expect=6e-06]} {Smed: dd_Smed_v6_61185_0_1, dd_Smed_v6_61185_0_1, [Score=70.9, Expect=1e-14]} {RNA1310_142905} |
50. | MligTC455_38657 | 292 | 6.08 | Mlig455_021581 | Neo: - Age: - |
CPLX1 | 1.858 | - | - | 0.899 | - | - | 0.959 | Mlig455_021581 {REF} {Length: 2085} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151, RNA1509_38047} {RNA1310_51275, RNA1509_38047} {RNA1509_38047, RNA815_22799} |
51. | MligTC455_40878 | 355 | 7.39 | Mlig455_014130 | Neo: - Age: - |
1.853 | 0.983 | - | - | - | 0.870 | - | Mlig455_014130 {REF} {Length: 1465} {RNA1509_7458} {RNA1310_36212} {RNA815_1610.1} | |
52. | MligTC455_53296 | 83 | 1.73 | Mlig455_060272 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.573/0.04615 |
LMO4 | 1.853 | 0.885 | - | 0.968 | - | - | - | Mlig455_060272 {REF} {Length: 1193} {Pfam: LIM domain [PF00412.24, score=30.9]} {Human: ENSG00000143013, LMO4, LIM domain only 4, [Score=54.3, Expect=4e-09]} {Mouse: ENSMUSG00000028266, Lmo4, LIM domain only 4, [Score=54.3, Expect=2e-09]} {Dmel: FBgn0265598, Bx, Beadex, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_27625_0_1, dd_Smed_v6_27625_0_1, [Score=53.5, Expect=4e-09]} {RNA1509_53632} {RNA1310_25695} {RNA815_42113} |
53. | MligTC455_44372 | 319 | 6.64 | Mlig455_016467 | Neo: - Age: - Region-enriched R2: 2.783/0.04502 |
1.851 | - | - | 0.889 | - | 0.962 | - | Mlig455_016467 {REF} {Length: 3430} {Pfam: Innexin [PF00876.20, score=423.2]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=107, Expect=2e-25]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=332, Expect=1e-110]} {Smed: dd_Smed_v6_6114_0_1, dd_Smed_v6_6114_0_1, [RH, Score=569, Expect=0.0]} {RNA1509_40288} {RNA1310_5443} {RNA815_16099} | |
54. | MligTC455_19547 | 11 | 0.23 | Mlig455_068540 | Neo: - Age: - |
CUBN | 1.839 | - | - | 0.848 | - | 0.991 | - | Mlig455_068540 {REF} {Length: 3105} {Pfam: CUB domain [PF00431.22, score=94.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=63.9, Expect=1e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=64.3, Expect=5e-10]} {Dmel: FBgn0261262, CG42613, [Score=95.9, Expect=5e-20]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=105, Expect=6e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_54691} |
55. | MligTC455_14294 | 37 | 0.78 | Mlig455_045370 | Neo: - Age: - |
PCDH1 | 1.833 | - | - | 0.861 | - | - | 0.972 | Mlig455_045370 {REF} {Length: 4947} {Pfam: Cadherin domain [PF00028.19, score=241.5]; Cadherin-like [PF08266.14, score=35.4]} {Human: ENSG00000156453, PCDH1, protocadherin 1, [Score=237, Expect=3e-63]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=239, Expect=1e-64]} {Dmel: FBgn0284247, ds, dachsous, [Score=203, Expect=2e-52]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=154, Expect=1e-37]} {Smed: dd_Smed_v6_21207_0_1, dd_Smed_v6_21207_0_1, [Score=263, Expect=7e-73]} {RNA1509_45430} {RNA1310_20787, RNA1509_45430} {RNA1509_45430, RNA815_48081} |
56. | MligTC455_17253 | 49 | 1.03 | Mlig455_019947 | Neo: - Age: - Region-enriched R2: 5.637/0.04654 |
1.833 | - | - | - | 0.872 | 0.961 | - | Mlig455_019947 {REF} {Length: 2249} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=23.5]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [RH, Score=148, Expect=3e-40]} {RNA1310_19413.1} {RNA815_30978} | |
57. | MligTC455_40574 | 185 | 3.86 | Mlig455_055994 | Neo: - Age: logFC(26M/2M)=0.739 |
1.832 | 0.952 | - | - | - | 0.880 | - | Mlig455_055994 {REF} {Length: 2305} {Pfam: Modifier of rudimentary (Mod(r)) protein [PF07200.15, score=20.1]} {RNA1509_55733} {RNA1310_23110} {RNA815_14988.1} | |
58. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
1.831 | - | - | 0.956 | - | 0.875 | - | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
59. | MligTC455_40596 | 131 | 2.74 | Mlig455_029755, Mlig455_029759, Mlig455_029851 | Neo: - Age: - |
PCDH17, PCDH9 | 1.827 | - | - | 0.963 | - | 0.864 | - | Mlig455_029755 {REF} {Length: 3844} {Pfam: Cadherin domain [PF00028.19, score=281.1]; Cadherin-like [PF08266.14, score=32.1]; Cadherin-like [PF16184.7, score=23.9]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=239, Expect=6e-64]; ENSG00000169851, PCDH7, protocadherin 7, [Score=228, Expect=1e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=236, Expect=3e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=227, Expect=1e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=227, Expect=4e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_2654_0_1, dd_Smed_v6_2654_0_1, [Score=251, Expect=4e-69]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029759 {REF} {Length: 2237} {Pfam: Cadherin domain [PF00028.19, score=169.5]; Cadherin-like [PF16184.7, score=19.9]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [Score=190, Expect=5e-51]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=181, Expect=2e-48]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [Score=189, Expect=1e-50]; ENSMUSG00000047307, Pcdhb13, protocadherin beta 13, [Score=187, Expect=1e-50]; ENSMUSG00000045689, Pcdhb4, protocadherin beta 4, [Score=185, Expect=9e-50]; ENSMUSG00000063687, Pcdhb5, protocadherin beta 5, [Score=184, Expect=2e-49]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=182, Expect=2e-48]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=180, Expect=4e-48]} {Dmel: FBgn0284247, ds, dachsous, [Score=158, Expect=3e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=126, Expect=5e-30]} {Smed: dd_Smed_v6_15376_0_1, dd_Smed_v6_15376_0_1, [Score=192, Expect=3e-52]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029851 {REF} {Length: 4327} {Pfam: Cadherin domain [PF00028.19, score=280.6]; Cadherin-like [PF08266.14, score=32.2]; Cadherin-like [PF16184.7, score=23.7]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=237, Expect=2e-63]; ENSG00000169851, PCDH7, protocadherin 7, [Score=226, Expect=3e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=225, Expect=5e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=226, Expect=7e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=4e-42]} {Smed: dd_Smed_v6_11605_0_1, dd_Smed_v6_11605_0_1, [Score=250, Expect=8e-69]} {RNA1509_47646} {RNA1310_26844, RNA1509_47646} {RNA1509_47646, RNA815_60336} |
60. | MligTC455_51178 | 190 | 3.97 | Mlig455_066114 | Neo: - Age: - |
1.825 | - | - | 0.863 | - | 0.962 | - | Mlig455_066114 {REF} {Length: 2408} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=58.5, Expect=4e-10]} {RNA1509_36492} {RNA1310_14560, RNA1509_36492} {RNA1509_36492, RNA815_5366} | |
61. | MligTC455_29169 | 108 | 2.25 | Mlig455_002330 | Neo: - Age: Up-Down-Down |
DNAH5 | 1.821 | 0.967 | - | - | - | 0.854 | - | Mlig455_002330 {REF} {Length: 14879} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=576.9]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=429.5]; Dynein heavy chain C-terminal domain [PF18199.3, score=313.2]; P-loop containing dynein motor region D4 [PF12780.9, score=303.1]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.8]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.2]; Microtubule-binding stalk of dynein motor [PF12777.9, score=144.8]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.4]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.5]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=21.9]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.3]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6256, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6232, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5094, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1294, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6936, Expect=0.0]} {RNA1509_39171, RNA1509_51275} {RNA1310_408, RNA1509_39171} {RNA1509_39171, RNA815_44.1} |
62. | MligTC455_02855 | 144 | 3 | Mlig455_000237 | Neo: - Age: - |
B3GALT2 | 1.819 | - | - | 0.852 | - | 0.967 | - | Mlig455_000237 {REF} {Length: 757} {Pfam: Galactosyltransferase [PF01762.23, score=48.0]} {Human: ENSG00000162630, B3GALT2, beta-1,3-galactosyltransferase 2, [Score=48.5, Expect=8e-07]} {Mouse: ENSMUSG00000033849, B3galt2, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, [Score=48.5, Expect=6e-07]} {Dmel: FBgn0035558, CG11357, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=88.2, Expect=2e-21]} {RNA1509_17403} {RNA1310_48383} {RNA815_28728} |
63. | MligTC455_10024 | 48 | 0.99 | Mlig455_065062 | Neo: - Age: - |
1.812 | - | - | - | - | 0.826 | 0.986 | Mlig455_065062 {REF} {Length: 3160} {RNA1310_7348} {RNA815_14995} | |
64. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
1.81 | - | - | 0.974 | - | 0.836 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
65. | MligTC455_13006 | 55 | 1.15 | Mlig455_044901 | Neo: - Age: - |
PCDH11Y | 1.804 | - | - | 0.837 | - | 0.967 | - | Mlig455_044901 {REF} {Length: 6092} {Pfam: Cadherin domain [PF00028.19, score=276.7]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=79.8]; Cadherin-like [PF08266.14, score=44.2]; Cadherin-like [PF16184.7, score=39.5]; Cadherin prodomain like [PF08758.13, score=30.3]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=292, Expect=5e-80]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=291, Expect=5e-80]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=281, Expect=9e-78]} {Dmel: FBgn0001075, ft, fat, [Score=239, Expect=3e-63]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=206, Expect=3e-53]} {Smed: dd_Smed_v6_18373_0_1, dd_Smed_v6_18373_0_1, [Score=290, Expect=1e-80]} {RNA1509_54067} {RNA1310_21501} {RNA815_32416} |
66. | MligTC455_10178 | 77 | 1.6 | Mlig455_017978 | Neo: - Age: - Region-enriched R7: 6.377/0.00000 |
GRM3 | 1.799 | - | - | - | - | 0.836 | 0.963 | Mlig455_017978 {REF} {Length: 3464} {Pfam: Receptor family ligand binding region [PF01094.30, score=224.4]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=185.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.1]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=670, Expect=0.0]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=725, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=625, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=803, Expect=0.0]} {RNA1310_41220} |
67. | MligTC455_15586 | 179 | 3.72 | Mlig455_061074 | Neo: - Age: - Region-enriched R2: 6.557/0.00000 |
1.795 | - | - | 0.956 | - | 0.839 | - | Mlig455_061074 {REF} {Length: 997} {Dmel: FBgn0013467, igl, igloo, [Score=43.5, Expect=3e-06]} {Smed: dd_Smed_v6_4783_0_82, dd_Smed_v6_4783_0_82, [Score=70.1, Expect=6e-16]} {RNA1509_36803} {RNA1310_35463} {RNA815_8499} | |
68. | MligTC455_44724 | 186 | 3.88 | Mlig455_024176 | Neo: - Age: - Region-enriched R7: 3.890/0.00870 |
1.794 | - | - | - | - | 0.954 | 0.840 | Mlig455_024176 {REF} {Length: 967} {RNA1310_84543} {RNA815_47586} | |
69. | MligTC455_11732 | 15 | 0.32 | Mlig455_001499, Mlig455_001517 | Neo: - Age: - |
GABBR2 | 1.793 | 0.808 | - | - | - | 0.985 | - | Mlig455_001499 {REF} {Length: 2516} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=166.2]; Receptor family ligand binding region [PF01094.30, score=21.1]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=219, Expect=7e-61]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=219, Expect=5e-61]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=202, Expect=4e-55]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=207, Expect=2e-57]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=151, Expect=1e-41]} {RNA1310_28849} {RNA815_36011} Mlig455_001517 {REF} {Length: 2539} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=166.0]; Receptor family ligand binding region [PF01094.30, score=52.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=236, Expect=1e-66]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=236, Expect=1e-66]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=220, Expect=6e-61]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=228, Expect=2e-64]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=152, Expect=8e-42]} {RNA1310_28849} {RNA815_36011} |
70. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
1.793 | - | - | 0.952 | - | 0.841 | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
71. | MligTC455_29261 | 34 | 0.71 | Mlig455_024258 | Neo: - Age: - |
1.791 | - | - | 0.831 | - | 0.960 | - | Mlig455_024258 {REF} {Length: 1171} {RNA1509_25125} {RNA1310_234.1} {RNA815_23.1} | |
72. | MligTC455_52165 | 671 | 13.99 | Mlig455_035531 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.972/0.00000 |
1.789 | - | - | 0.983 | - | 0.806 | - | Mlig455_035531 {REF} {Length: 648} {RNA1509_42191} {RNA1310_75398, RNA1509_42191} {RNA1509_42191, RNA815_40298} | |
73. | MligTC455_14184 | 23 | 0.48 | Mlig455_026684 | Neo: - Age: - |
1.786 | 0.968 | - | 0.818 | - | - | - | Mlig455_026684 {REF} {Length: 674} {NoTransDecoderORF} {RNA1310_72508} {RNA815_40858} | |
74. | MligTC455_12661 | 25 | 0.51 | Mlig455_063823 | Neo: - Age: - |
1.783 | - | - | 0.955 | - | 0.828 | - | Mlig455_063823 {REF} {Length: 1191} {RNA1310_131240} | |
75. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 1.781 | - | - | 0.823 | - | - | 0.958 | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |
76. | MligTC455_18897 | 296 | 6.16 | Mlig455_013372 | Neo: - Age: - Region-enriched R2: 3.633/0.00016 |
RGS20 | 1.78 | - | - | 0.818 | - | 0.962 | - | Mlig455_013372 {REF} {Length: 1310} {TRANSSPLICED} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=122.1]} {Human: ENSG00000147509, RGS20, regulator of G protein signaling 20, [RH, Score=201, Expect=2e-65]; ENSG00000091844, RGS17, regulator of G protein signaling 17, [RH, Score=196, Expect=5e-64]; ENSG00000171700, RGS19, regulator of G protein signaling 19, [RH, Score=194, Expect=3e-63]} {Mouse: ENSMUSG00000002459, Rgs20, regulator of G-protein signaling 20, [RH, Score=199, Expect=5e-65]; ENSMUSG00000019775, Rgs17, regulator of G-protein signaling 17, [RH, Score=198, Expect=8e-65]} {Dmel: FBgn0028743, Dhit, Double hit, [RH, Score=213, Expect=7e-70]} {Celegans: WBGene00004345, rgs-2, Regulator of G-protein signaling rgs-2, [RH, Score=173, Expect=9e-56]} {Smed: dd_Smed_v6_8877_0_1, dd_Smed_v6_8877_0_1, [RH, Score=187, Expect=4e-58]} {RNA1509_49447} {RNA1310_26662, RNA1509_49447} {RNA1509_49447, RNA815_5788} |
77. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.778 | - | - | 0.828 | - | 0.950 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
78. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
1.772 | - | - | 0.820 | - | 0.952 | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
79. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.771 | - | - | 0.815 | - | 0.956 | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
80. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 1.765 | - | - | 0.812 | - | 0.953 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
81. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 1.761 | 0.771 | - | - | - | 0.990 | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
82. | MligTC455_35004 | 42 | 0.87 | Mlig455_070373 | Neo: - Age: Up-Down-Up |
SVEP1 | 1.755 | - | - | 0.774 | - | 0.981 | - | Mlig455_070373 {REF} {Length: 2896} {Pfam: EGF-like domain [PF00008.29, score=30.9]; EGF-like domain [PF07974.15, score=25.8]} {Human: ENSG00000165124, SVEP1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=52.4, Expect=1e-06]; ENSG00000148400, NOTCH1, notch 1, [Score=51.2, Expect=3e-06]} {Mouse: ENSMUSG00000047793, Sned1, sushi, nidogen and EGF-like domains 1, [Score=55.8, Expect=6e-08]} {RNA1509_48097} {RNA1310_29794} {RNA815_16285} |
83. | MligTC455_46470 | 552 | 11.5 | Mlig455_066293 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.795/0.00284 |
1.748 | - | - | 0.790 | - | 0.958 | - | Mlig455_066293 {REF} {Length: 896} {RNA1509_9692} {RNA1310_57568} {RNA815_29793} | |
84. | MligTC455_24548 | 39 | 0.8 | Mlig455_031981 | Neo: - Age: - |
ROBO1 | 1.74 | - | - | - | - | 0.784 | 0.956 | Mlig455_031981 {REF} {Length: 4163} {Pfam: Immunoglobulin domain [PF13927.8, score=128.2]; Immunoglobulin I-set domain [PF07679.18, score=115.2]; Immunoglobulin domain [PF00047.27, score=78.6]; Immunoglobulin V-set domain [PF07686.19, score=73.6]; Immunoglobulin domain [PF13895.8, score=71.9]; Fibronectin type III domain [PF00041.23, score=22.4]} {Human: ENSG00000169855, ROBO1, roundabout guidance receptor 1, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032128, Robo3, roundabout guidance receptor 3, [Score=133, Expect=6e-31]} {Dmel: FBgn0005631, robo1, roundabout 1, [Score=139, Expect=4e-33]} {Celegans: WBGene00004729, sax-3, [Score=132, Expect=6e-31]} {Smed: dd_Smed_v6_8494_0_1, dd_Smed_v6_8494_0_1, [Score=239, Expect=1e-64]} {RNA1310_122847} {RNA815_62158} |
85. | MligTC455_42973 | 126 | 2.63 | Mlig455_049802 | Neo: - Age: - Region-enriched R8: 3.350/0.01883 |
PRR9 | 1.738 | 0.952 | - | 0.786 | - | - | - | Mlig455_049802 {REF} {Length: 4186} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=48.1, Expect=2e-06]} {RNA1310_38620} {RNA815_23864} |
86. | MligTC455_46467 | 4047 | 84.32 | Mlig455_009033 | Neo: - Age: Down-Up-Down Region-specific R2: 2.894 Region-enriched R2: 2.264/0.00006 Regeneration-downregulated BL: -2.309 Regeneration-depleted BL: -2.309 |
1.737 | - | - | 0.784 | - | 0.953 | - | Mlig455_009033 {REF} {Length: 1015} {RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1310_57568, RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1509_10834, RNA1509_4025, RNA1509_9692, RNA815_29793} | |
87. | MligTC455_48935 | 27 | 0.57 | Mlig455_041669 | Neo: - Age: - |
1.734 | - | - | 0.973 | - | 0.761 | - | Mlig455_041669 {REF} {Length: 1052} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=56.2, Expect=8e-10]} {RNA1310_58309} {RNA815_39074} | |
88. | MligTC455_21665 | 1283 | 26.74 | Mlig455_000443, Mlig455_000504 | Neo: - Age: logFC(26M/2M)=-0.231 Region-specific R2: 3.326 Region-enriched R2: 2.174/0.00141 |
PPP3R1 | 1.731 | - | - | - | - | 0.986 | 0.745 | Mlig455_000443 {REF} {Length: 1489} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613, RNA1509_39549} {RNA1310_16848.2, RNA1509_14613, RNA1509_39549} {RNA1509_14613, RNA1509_39549, RNA815_6272} Mlig455_000504 {REF} {Length: 1689} {Pfam: EF hand [PF00036.34, score=90.0]; EF-hand domain pair [PF13499.8, score=84.5]; EF-hand domain [PF13405.8, score=71.9]; EF hand [PF13202.8, score=69.8]; EF-hand domain pair [PF13833.8, score=63.4]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=25.4]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=290, Expect=2e-100]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=290, Expect=1e-100]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=283, Expect=4e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=274, Expect=3e-94]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=283, Expect=3e-98]} {RNA1509_39549} {RNA1310_16848.2} {RNA815_6272} |
89. | MligTC455_27312 | 34 | 0.71 | Mlig455_031812 | Neo: - Age: - |
TLL2 | 1.729 | - | - | 0.767 | - | 0.962 | - | Mlig455_031812 {REF} {Length: 3695} {Pfam: CUB domain [PF00431.22, score=151.7]} {Human: ENSG00000095587, TLL2, tolloid like 2, [Score=67.4, Expect=1e-10]; ENSG00000107611, CUBN, cubilin, [Score=66.6, Expect=3e-10]} {Mouse: ENSMUSG00000025013, Tll2, tolloid-like 2, [Score=70.5, Expect=9e-12]} {Dmel: FBgn0261262, CG42613, [Score=97.1, Expect=4e-20]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=80.5, Expect=3e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [RH, Score=276, Expect=6e-80]} {RNA1509_30788} {RNA1310_1673.1} {RNA815_5892} |
90. | MligTC455_15759 | 90 | 1.87 | Mlig455_011069 | Neo: - Age: - |
PCDH9 | 1.728 | - | - | - | - | 0.951 | 0.777 | Mlig455_011069 {REF} {Length: 3981} {Pfam: Cadherin domain [PF00028.19, score=243.4]; Cadherin-like [PF16184.7, score=38.3]; Cadherin-like [PF08266.14, score=33.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=271, Expect=2e-74]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=266, Expect=4e-73]} {Dmel: FBgn0001075, ft, fat, [Score=216, Expect=2e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=163, Expect=3e-40]} {Smed: dd_Smed_v6_16610_0_1, dd_Smed_v6_16610_0_1, [RH, Score=271, Expect=6e-76]} {RNA1310_20741} {RNA815_3048.1} |
91. | MligTC455_41608 | 65 | 1.36 | Mlig455_039948 | Neo: - Age: Down-Up-Down |
1.728 | 0.956 | - | 0.772 | - | - | - | Mlig455_039948 {REF} {Length: 4005} {RNA1310_25006} {RNA815_53385} | |
92. | MligTC455_24525 | 354 | 7.37 | Mlig455_007869 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 2.053/0.02539 |
MAST1 | 1.725 | 0.759 | - | 0.966 | - | - | - | Mlig455_007869 {REF} {Length: 5535} {Pfam: Domain of unknown function (DUF1908) [PF08926.13, score=296.2]; Protein kinase domain [PF00069.27, score=197.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=82.3]; PDZ domain [PF17820.3, score=29.9]; PDZ domain [PF13180.8, score=23.9]; PDZ domain [PF00595.26, score=23.5]; ABC1 atypical kinase-like domain [PF03109.18, score=23.1]; Kinase-like [PF14531.8, score=18.9]} {Human: ENSG00000105613, MAST1, microtubule associated serine/threonine kinase 1, [RH, Score=696, Expect=0.0]; ENSG00000069020, MAST4, microtubule associated serine/threonine kinase family member 4, [RH, Score=687, Expect=0.0]; ENSG00000086015, MAST2, microtubule associated serine/threonine kinase 2, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000053693, Mast1, microtubule associated serine/threonine kinase 1, [RH, Score=697, Expect=0.0]; ENSMUSG00000034751, Mast4, microtubule associated serine/threonine kinase family member 4, [RH, Score=682, Expect=0.0]; ENSMUSG00000003810, Mast2, microtubule associated serine/threonine kinase 2, [RH, Score=675, Expect=0.0]; ENSMUSG00000031833, Mast3, microtubule associated serine/threonine kinase 3, [RH, Score=664, Expect=0.0]; ENSMUSG00000110763, Mast3, microtubule associated serine/threonine kinase 3, [RH, Score=664, Expect=0.0]} {Dmel: FBgn0267390, dop, drop out, [RH, Score=510, Expect=3e-153]} {Celegans: WBGene00002192, kin-4, KIN-4 protein; Protein KINase, [RH, Score=563, Expect=8e-176]} {Smed: dd_Smed_v6_2028_0_1, dd_Smed_v6_2028_0_1, [RH, Score=682, Expect=0.0]} {RNA1509_37039} {RNA1310_2344.2, RNA1509_37039} {RNA1509_37039, RNA815_8686} |
93. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 1.724 | - | - | - | - | 0.741 | 0.983 | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
94. | MligTC455_17187 | 85 | 1.77 | Mlig455_040722 | Neo: - Age: logFC(26M/2M)=-0.644 |
SCNN1B | 1.723 | - | - | - | - | 0.758 | 0.965 | Mlig455_040722 {REF} {Length: 2368} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=64.3, Expect=5e-10]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_25838_0_1, dd_Smed_v6_25838_0_1, [Score=230, Expect=3e-67]} {RNA1509_57515} {RNA1310_24808, RNA1509_57515} {RNA1509_57515, RNA815_46525} |
95. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
1.722 | 0.748 | - | - | - | - | 0.974 | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
96. | MligTC455_43959 | 93 | 1.94 | Mlig455_020049, Mlig455_022295 | Neo: - Age: Down-Up-Up |
1.72 | - | - | - | - | 0.966 | 0.754 | Mlig455_020049 {REF} {Length: 1131} {RNA1509_47842} {RNA1310_6450.2} {RNA815_45397} Mlig455_022295 {REF} {Length: 1494} {RNA1509_47842} {RNA1310_6450.2} {RNA815_45397} |
|
97. | MligTC455_45968 | 43 | 0.89 | Mlig455_058916 | Neo: - Age: - |
1.715 | - | - | 0.758 | - | - | 0.957 | Mlig455_058916 {REF} {Length: 3026} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=53.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=29.4]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [RH, Score=105, Expect=7e-25]} {RNA1310_38706} | |
98. | MligTC455_23875 | 10 | 0.2 | Mlig455_047531 | Neo: - Age: - |
1.71 | - | - | 0.736 | - | 0.974 | - | Mlig455_047531 {REF} {Length: 2692} {Pfam: Otopetrin [PF03189.15, score=34.6]} {RNA1509_19550} {RNA1310_33220} {RNA815_53207} | |
99. | MligTC455_52310 | 100 | 2.08 | Mlig455_014082 | Neo: - Age: - Region-enriched R2: 4.038/0.02037 |
1.705 | - | - | 0.750 | - | 0.955 | - | Mlig455_014082 {REF} {Length: 1503} {Smed: dd_Smed_v6_12908_0_1, dd_Smed_v6_12908_0_1, [Score=52.4, Expect=1e-08]} {RNA1509_50808} {RNA1310_3413} {RNA815_20403} | |
100. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.699 | 0.705 | - | - | - | 0.994 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} |